Click for St. Louis, Missouri Forecast

// a href = ./ // St Louis News, Weather, Sports, The Big 550 AM, St Louis Traffic, Breaking News in St Louis

Online pharmacy:fesmag.com/tem

Have you a sex problem? Please visit our site:fesmag.com/medic

Site map
 
 
 

MERCK JOINS COMPANIES ENDING CHIMPANZEE RESEARCH

Rate this item
(0 votes)

TRENTON, N.J. (AP) -- Drugmaker Merck & Co. is joining two dozen other pharmaceutical companies and contract laboratories in committing to not use chimpanzees for research.

The growing trend could mean roughly 1,000 chimps in the U.S. used for research or warehoused for many years in laboratory cages could be "retired" to sanctuaries by around 2020.

That's according to Kathleen Conlee of the Humane Society of the United States, which seven years ago began urging companies to phase out all chimp research.

The trend is driven by improved technology, animal alternatives and pressure from animal rights groups, the National Institutes of Health and Congress.

Last June, reacting to an Institute of Medicine study Congress had requested that concluded nearly all chimp research is unnecessary, the NIH announced it would retire and send about 90 percent of government-owned research chimps to the Chimp Haven sanctuary in Keithville, La. It's now home to about 160 chimps, with nearly 60 more to arrive soon.

After several years, the NIH plans to decide whether the remaining chimps in government labs can also be moved to sanctuaries. Roughly 450 other chimps are owned by private labs that do research under contract for drugmakers and other companies.

"It's been a long road in trying to end the use of chimpanzees in research, and we're now at a turning point," Conlee told The Associated Press Thursday. "We're going to keep on (advocating) until the chimpanzees in laboratories are all in sanctuaries."

Merck spokeswoman Caroline Lappetito said the company, based in Whitehouse Station, N.J., decided late last year to stop research on chimpanzees and switch to alternative types of testing.

"The science has advanced, and we don't really need it," Lappetito said.

Merck, the world's third-biggest drugmaker, is the largest to make the switch.

Companies that develop medicines and consumer products such as cosmetics have long used animals to test safety and effectiveness. In the case of experimental medicines, drugmakers must test on animals before the Food and Drug Administration will let them do the human testing needed for approval of a new therapy.

Nearly all animal experiments in the U.S. involve mice, rats and guinea pigs, although some are done on dogs and great apes, almost always chimpanzees.

But animal research, particularly on primates and pet species such as dogs and rabbits, has long drawn criticism from animal rights groups, including protests outside laboratories and at annual shareholder meetings. Besides calling the practice inhumane, activists often have alleged - and sometimes proven - that animals were being abused.

Many companies previously said it was necessary to test potential medicines and vaccines on nonhuman primates because they needed an animal in which the anatomy and disease course were very similar to that in humans.

That thinking changed as technology allowed researchers to do initial testing via computer simulations, in bacteria or cells, and in animals as small as fish. Many drugmakers also found ways to do testing on far fewer animals and to limit the discomfort of experiments by using painkillers and tranquilizers. And many of the companies pledging not to use chimps in the future never did so.

British drugmaker GlaxoSmithKline PLC was one of the first to stop research in chimps, back in 2008.

"Research we did on nonhuman primates was kept to a minimum" even before that, said spokeswoman Melinda Stubee.

Because chimpanzees used for commercial medical research generally are confined in the labs of contract testing companies, Conlee said the Humane Society is trying to convince them that there's no longer enough demand to continue warehousing chimpanzees for potential future work. She hopes they'll pay to support those chimpanzees in one of five U.S. accredited sanctuaries for former research chimps.

----

Online:

HTTP://WWW.HUMANESOCIETY.ORG/ISSUES/CHIMPANZEE-RESEARCH/

© 2014 THE ASSOCIATED PRESS. ALL RIGHTS RESERVED. THIS MATERIAL MAY NOT BE PUBLISHED, BROADCAST, REWRITTEN OR REDISTRIBUTED. Learn more about our PRIVACY POLICY and TERMS OF USE.

Last modified on Friday, 31 January 2014 10:39

Latest News

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Prev Next
REPORT: TEEN HPV VACCINATION RATE STILL LAGGING

REPORT: TEEN HPV VACCINATION RATE STILL LAGGING

ATLANTA (AP) -- Only about half of U.S. teenage girls have gotten a controversial cervical cancer vaccine - a rate that's changed little in three years. "We're dropping the ball...

VIETNAM RELEASES DENGUE-BLOCKING MOSQUITO

VIETNAM RELEASES DENGUE-BLOCKING MOSQUITO

TRI NGUYEN ISLAND, Vietnam (AP) -- Nguyen Thi Yen rolls up the sleeves of her white lab coat and delicately slips her arms into a box covered by a sheath of mesh netting. Immedi...

Steroid use much higher among gay and bi teen boys

CHICAGO (AP) — Gay and bisexual teen boys use illicit steroids at a rate almost six times higher than do straight kids, a "dramatic disparity" that points up a need to reach out...

PA. STUDENTS' ROBOTIC ARM CAN MAKE YOU STRONGER

PA. STUDENTS' ROBOTIC ARM CAN MAKE YOU STRONGER

PHILADELPHIA (AP) -- Need a hand lifting something? A robotic device invented by University of Pennsylvania engineering students can help its wearer carry an additional 40 pound...

DRINKING LINKED TO FASTER MENTAL DECLINE IN MEN

DRINKING LINKED TO FASTER MENTAL DECLINE IN MEN

NEW YORK (AP) -- Middle-aged men risk a faster mental decline as they age if they've been drinking heavily for years, new research suggests. ...

NOTRE DAME SUES OVER BIRTH CONTROL MANDATE

NOTRE DAME SUES OVER BIRTH CONTROL MANDATE

SOUTH BEND, Ind. (AP) -- The University of Notre Dame on Tuesday filed another lawsuit opposing portions of the federal health care overhaul that forces it to provide health ins...

Centralizing organ removal may benefit transplants

Centralizing organ removal may benefit transplants

   Transplant medicine could be on the cusp of a new way to accomplish a critical task -- efficiently getting the organ from the donor and into the recipient. &nbs...

US SUICIDE RATE ROSE SHARPLY AMONG MIDDLE-AGED

US SUICIDE RATE ROSE SHARPLY AMONG MIDDLE-AGED

NEW YORK (AP) -- The suicide rate among middle-aged Americans climbed a startling 28 percent in a decade, a period that included the recession and the mortgage crisis, the governme...

© 2013 KTRS All Rights Reserved